Association of psoriasis with the VEGF gene polymorphism in the northern Polish population

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 3, 2013, Pages 319-323

  Zablotna, M ^a   Sobjanek, M ^a   Nedoszytko, B ^a   Lange, M ^a   Kozicka, D ^a   Glen, J ^a   Roszkiewicz, J ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PSORIASIS; RISK FACTOR;

ADOLESCENT; ADULT; ALLELES; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PSORIASIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84874105933     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04393.x     Document Type: Article

References (25)

1. Creamer D, Sullivan D, Bicknell R, Barker J,. Angiogenesis in psoriasis. Angiogenesis 2002; 5: 231-236.
2. Detmar M, Brown LF, Claffey KP, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994; 180: 1141-1146.
3. Bhushan M, McLaughlin B, Weiss JB, et al. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol 1999; 141: 1054-1060.
4. Xia YP, Li B, Hylton D, et al. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 2003; 102: 161-168.
5. Vincenti V, Cassano C, Rocchi M, et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996; 93: 1493-1495.
6. Shahbazi M, Fryer AA, Pravica V, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002; 13: 260-264.
7. Howell WM, Bateman AC, Turner SJ, et al. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun 2002; 3: 229-232.
8. McCarron SL, Edwards S, Evans PR, et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 2002; 62: 3369-3372.
9. Koukourakis MI, Papazoglou D, Giatromanolaki A, et al. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 2004; 46: 293-298.
10. Young HS, Summers AM, Bhushan M, et al. Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol 2004; 122: 209-215.
11. Young HS, Summers AM, Read IR, et al. Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. J Invest Dermatol 2006; 126: 453-459.
12. Ku KT, Wan L, Peng HC, et al. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancer. Oral Oncol 2005; 41: 497-502.
13. Barile S, Medda E, Nisticò L, et al. Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis. Exp Dermatol 2006; 15: 368-376.
14. Watson CJ, Webb NJ, Bottomley MJ, et al. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12: 1232-1235.
15. Stephens M, Smith NJ, Donnelly P,. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
16. Stephens M, Donnelly P,. A comparison of bayesian methods for haplotype reconstruction. Am J Hum Genet 2003; 73: 1162-1169.
17. Wang Z, Liang W, Zhang B,. Single nucleotide polymorphisms of VEGF gene and psoriasis risk. J Dermatol Sci 2008; 49: 263-265.
18. Wongpiyabovorn J, Yooyongsatit S, Ruchusatsawat K, et al. Association of the CTG (-2578/-460/+405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis. Tissue Antigens 2008; 72: 458-463.
19. Lee JH, Cho EY, Namkung JH, et al. Single-nucleotide polymorphisms and haplotypes in the VEGF receptor 3 gene and the haplotype GC in the VEGFA gene are associated with psoriasis in Koreans. J Invest Dermatol 2008; 128: 1599-1603.
20. Wu J, Ren X, Zhang X, et al. The vascular endothelial growth factor +405 G/C polymorphism in psoriasis. J Dermatol Sci 2010; 57: 62-63.
21. Butt C, Lim S, Greenwood C, et al. VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. BMC Musculoskelet Disord 2007; 4: 1.
22. Nofal A, Al-Makhzangy I, Attwa E, et al. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control. J Eur Acad Dermatol Venereol 2009; 23: 803-806.
23. Diaz BV, Lenoir MC, Ladoux A, et al. Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. J Biol Chem 2000; 275: 642-650.
24. Huez I, Bornes S, Bresson D, et al. New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation. Mol Endocrinol 2001; 15: 2197-2210.
25. Detmar M,. Evidence for vascular endothelial growth factor (VEGF) as a modifier gene in psoriasis. J Invest Dermatol 2004; 122: 14-15.